I'd like to point out for any new investors that t
Post# of 72440
Posted On: 08/18/2016 11:32:56 AM
I'd like to point out for any new investors that the peer reviewed article (singular) has never been promised by Leo. CTIX did however, release the following information in a PR released on Jan 20, 2015:
"Additionally, the Principal Investigators for the Kevetrin trial have requested that the Company start preparing a presentation to be used for an article on the safety and pharmacological effect of Kevetrin on multiple cancer lines as demonstrated in the clinical trial. Cellceutix interprets this recommendation as a very optimistic sign regarding anticipated outcomes for the trial and clinical advancement of Kevetrin." - See more at: http://cellceutix.com/cellceutix-reports-sple...GxCg5.dpuf
CTIX is not in charge of writing the article and therefore have no control over it's completion. It is also worth noting that peer reviewed articles typically take a year or more to review and vet before being published. So given this information, the time it takes just to write the article in the first place, and the fact that it has been a year and a half since CTIX received the initial request for information to assist, I'd say that things are proceeding right on an reasonable timeline. I am just as anxious as any other investor to get K information into an accredited and respected journal, but to say Leo is failing is a total misrepresentation.
"Additionally, the Principal Investigators for the Kevetrin trial have requested that the Company start preparing a presentation to be used for an article on the safety and pharmacological effect of Kevetrin on multiple cancer lines as demonstrated in the clinical trial. Cellceutix interprets this recommendation as a very optimistic sign regarding anticipated outcomes for the trial and clinical advancement of Kevetrin." - See more at: http://cellceutix.com/cellceutix-reports-sple...GxCg5.dpuf
CTIX is not in charge of writing the article and therefore have no control over it's completion. It is also worth noting that peer reviewed articles typically take a year or more to review and vet before being published. So given this information, the time it takes just to write the article in the first place, and the fact that it has been a year and a half since CTIX received the initial request for information to assist, I'd say that things are proceeding right on an reasonable timeline. I am just as anxious as any other investor to get K information into an accredited and respected journal, but to say Leo is failing is a total misrepresentation.
(9)
(0)Innovation Pharmaceuticals Inc (IPIX) Stock Research Links
Scroll down for more posts ▼